Addus HomeCare (NASDAQ:ADUS) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Addus HomeCare (NASDAQ:ADUS - Get Free Report) announced its earnings results on Monday. The company reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.02, Briefing.com reports. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same period in the previous year, the firm posted $1.03 earnings per share. The company's revenue was up 7.1% on a year-over-year basis.

Addus HomeCare Stock Performance

ADUS traded down $4.79 during trading hours on Tuesday, reaching $124.17. The company's stock had a trading volume of 242,435 shares, compared to its average volume of 131,643. The company's 50-day moving average is $129.93 and its 200-day moving average is $120.66. Addus HomeCare has a 52 week low of $81.51 and a 52 week high of $136.12. The firm has a market cap of $2.25 billion, a PE ratio of 28.13, a price-to-earnings-growth ratio of 2.29 and a beta of 1.04.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company's stock, valued at $961,687.35. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 over the last ninety days. Insiders own 4.60% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ADUS. TD Cowen boosted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a research report on Thursday, August 8th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research report on Monday, September 23rd. Stephens reiterated an "overweight" rating and set a $138.00 target price on shares of Addus HomeCare in a report on Tuesday, August 6th. KeyCorp initiated coverage on Addus HomeCare in a research report on Friday, October 11th. They set an "overweight" rating and a $150.00 price objective for the company. Finally, Macquarie restated an "outperform" rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Addus HomeCare has an average rating of "Moderate Buy" and an average price target of $131.38.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.